VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $5,230,000 | -27.0% | 328,600 | -4.6% | 0.73% | -36.9% |
Q4 2017 | $7,165,000 | +62.4% | 344,300 | +35.7% | 1.16% | +34.0% |
Q2 2017 | $4,413,000 | +1716.0% | 253,800 | +2463.6% | 0.86% | +1248.4% |
Q3 2016 | $243,000 | +45.5% | 9,900 | +19.7% | 0.06% | +30.6% |
Q2 2016 | $167,000 | -23.0% | 8,270 | 0.0% | 0.05% | -33.8% |
Q1 2016 | $217,000 | -74.0% | 8,270 | 0.0% | 0.07% | -76.7% |
Q4 2015 | $836,000 | -47.3% | 8,270 | -6.8% | 0.32% | -40.6% |
Q3 2015 | $1,585,000 | -19.5% | 8,870 | 0.0% | 0.54% | -10.2% |
Q2 2015 | $1,968,000 | +37.1% | 8,870 | +22.0% | 0.60% | +61.5% |
Q1 2015 | $1,435,000 | +73.7% | 7,270 | +26.0% | 0.37% | +73.2% |
Q4 2014 | $826,000 | +105.5% | 5,770 | +87.9% | 0.21% | +66.4% |
Q3 2014 | $402,000 | -79.8% | 3,070 | -80.5% | 0.13% | -71.7% |
Q2 2014 | $1,994,000 | -16.1% | 15,770 | -12.7% | 0.45% | -32.1% |
Q1 2014 | $2,378,000 | -12.2% | 18,070 | -21.7% | 0.67% | -15.8% |
Q4 2013 | $2,707,000 | +7.1% | 23,070 | -4.9% | 0.79% | +5.3% |
Q3 2013 | $2,527,000 | +72.6% | 24,270 | +43.0% | 0.75% | +57.0% |
Q2 2013 | $1,464,000 | – | 16,970 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |